JBM (HEALTHCARE) LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.86 HKD | -2.27% |
|
-2.27% | -18.10% |
Valuation
| Fiscal Period: March | 2021 | 2022 | 2023 |
|---|---|---|---|
| Capitalization 1 | 1,198 | 813.3 | 986.8 |
| Enterprise Value (EV) 1 | 1,364 | 947.1 | 1,003 |
| P/E ratio | 48.3 x | 33 x | 16.9 x |
| Yield | - | - | 2.78% |
| Capitalization / Revenue | 3.02 x | 2 x | 1.9 x |
| EV / Revenue | 3.44 x | 2.33 x | 1.93 x |
| EV / EBITDA | 13 x | 12.6 x | 9.94 x |
| EV / FCF | 33,299,281 x | 19,429,315 x | 7,619,993 x |
| FCF Yield | 0% | 0% | 0% |
| Price to Book | 1.32 x | 0.88 x | 0.99 x |
| Nbr of stocks (in thousands) | 893,686 | 893,686 | 913,686 |
| Reference price 2 | 1.340 | 0.9100 | 1.080 |
| Announcement Date | 27/07/21 | 27/07/22 | 07/07/23 |
1HKD in Million2HKD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 264.3 | 307.5 | 381.5 | 397.2 | 406.1 | 520.3 |
| EBITDA 1 | 74.46 | 85.86 | 78.66 | 105.1 | 74.9 | 101 |
| EBIT 1 | 52.39 | 64.3 | 53.24 | 73.37 | 41.3 | 70.48 |
| Operating Margin | 19.82% | 20.91% | 13.95% | 18.47% | 10.17% | 13.54% |
| Earnings before Tax (EBT) 1 | 51.82 | 69.85 | 53.97 | 41.68 | 30.74 | 76.9 |
| Net income 1 | 42.38 | 52.46 | 41.02 | 22.6 | 24.62 | 57.09 |
| Net margin | 16.03% | 17.06% | 10.75% | 5.69% | 6.06% | 10.97% |
| EPS | - | - | 0.0568 | 0.0278 | 0.0275 | 0.0641 |
| Free Cash Flow | - | 28.92 | 193.5 | 40.97 | 48.75 | 131.7 |
| FCF margin | - | 9.41% | 50.71% | 10.32% | 12% | 25.31% |
| FCF Conversion (EBITDA) | - | 33.69% | 245.97% | 39% | 65.08% | 130.39% |
| FCF Conversion (Net income) | - | 55.14% | 471.63% | 181.3% | 197.99% | 230.64% |
| Dividend per Share | - | - | - | - | - | 0.0300 |
| Announcement Date | 25/01/21 | 25/01/21 | 25/01/21 | 27/07/21 | 27/07/22 | 07/07/23 |
1HKD in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 845 | 947 | 417 | 167 | 134 | 16.6 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 11.35 x | 11.03 x | 5.304 x | 1.588 x | 1.787 x | 0.1645 x |
| Free Cash Flow | - | 28.9 | 193 | 41 | 48.7 | 132 |
| ROE (net income / shareholders' equity) | - | 39.6% | 9.92% | 3.69% | 2.43% | 6.33% |
| ROA (Net income/ Total Assets) | - | 3.32% | 2.5% | 3.34% | 1.9% | 3.22% |
| Assets 1 | - | 1,578 | 1,640 | 677.5 | 1,294 | 1,773 |
| Book Value Per Share | - | - | 0.9100 | 1.010 | 1.040 | 1.090 |
| Cash Flow per Share | - | - | 0.1000 | 0.1100 | 0.0800 | 0.1700 |
| Capex 1 | 10.6 | 9.14 | 4.52 | 23 | 7.06 | 8.13 |
| Capex / Sales | 4% | 2.97% | 1.19% | 5.78% | 1.74% | 1.56% |
| Announcement Date | 25/01/21 | 25/01/21 | 25/01/21 | 27/07/21 | 27/07/22 | 07/07/23 |
1HKD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -18.10% | 91.16M | |
| +39.33% | 6.11B | |
| -18.38% | 4.35B | |
| -9.17% | 3.19B | |
| +3.98% | 3.15B | |
| -3.41% | 2.51B | |
| +48.74% | 1.98B | |
| -4.82% | 1.74B | |
| -1.24% | 1.63B | |
| -8.96% | 1.6B |
- Stock Market
- Equities
- 2161 Stock
- Financials JBM (Healthcare) Limited
